CIK 0001484612
- Accelerated filer
- Smaller reporting company
Outset Medical, Inc.
Sign in to watch- Ticker
- OM
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 200514392
- Phone
- +1 669-231-8200
- Business address
- 3052 ORCHARD DRIVE, SAN JOSE, CA, 95134
- Former names
- Home Dialysis Plus, Ltd.
- Open-market buys, last 90 days
- $870,260
- in 1 filing
- Open-market sales, last 90 days
- $28,997
- in 2 filings
Net +$841,264. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-01 | Trigg Leslie Chair and CEO | Option exercise 10b5-1 | +20,000 | $4.11 | $82K | 429,489 |
| 2023-08-01 | Trigg Leslie Chair and CEO | Sale 10b5-1 | −20,000 | $20.22 | $404K | 409,489 |
| 2023-08-01 | Trigg Leslie Chair and CEO | Option exercise · Performance Options (right to buy) 10b5-1 | −20,000 | 25,418 | ||
| 2023-08-01 | Ahmed Nabeel Chief Financial Officer | Sale 10b5-1 | −990 | $20.07 | $20K | 90,736 |
| 2023-07-24 | Nash Marc VP Manufacturing | Grant or award | +6,000 | 45,195 | ||
| 2023-07-24 | Nash Marc VP Manufacturing | Grant or award | +338 | 45,533 | ||
| 2023-07-19 | Brottem John L. General Counsel | Option exercise 10b5-1 | +1,415 | $9.48 | $13K | 60,360 |
| 2023-07-19 | Brottem John L. General Counsel | Sale 10b5-1 | −1,415 | $20.00 | $28K | 58,945 |
| 2023-07-19 | Brottem John L. General Counsel | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,415 | 15,560 | ||
| 2023-07-03 | Trigg Leslie Chair and CEO | Option exercise 10b5-1 | +20,000 | $4.11 | $82K | 429,489 |
| 2023-07-03 | Trigg Leslie Chair and CEO | Sale 10b5-1 | −20,000 | $20.90 | $418K | 409,489 |
| 2023-07-03 | Trigg Leslie Chair and CEO | Option exercise · Performance Options (right to buy) 10b5-1 | −20,000 | 45,418 | ||
| 2023-07-03 | Ahmed Nabeel Chief Financial Officer | Sale 10b5-1 | −990 | $21.70 | $21K | 91,726 |
| 2023-06-20 | Brottem John L. General Counsel | Option exercise 10b5-1 | +1,414 | $9.48 | $13K | 60,359 |
| 2023-06-20 | Brottem John L. General Counsel | Sale 10b5-1 | −1,414 | $21.97 | $31K | 58,945 |
| 2023-06-20 | Brottem John L. General Counsel | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,414 | 16,975 | ||
| 2023-06-01 | Trigg Leslie Chair and CEO | Option exercise 10b5-1 | +20,000 | $4.11 | $82K | 429,489 |
| 2023-06-01 | Trigg Leslie Chair and CEO | Sale 10b5-1 | −20,000 | $21.10 | $422K | 409,489 |
| 2023-06-01 | Trigg Leslie Chair and CEO | Option exercise · Performance Options (right to buy) 10b5-1 | −20,000 | 65,418 | ||
| 2023-06-01 | Ahmed Nabeel Chief Financial Officer | Sale 10b5-1 | −990 | $20.83 | $21K | 92,716 |
Page 11 of 18 · 343 trades